Dexcom (NSDQ:DXCM) announced today that it launched the new Dexcom One continuous glucose monitoring (CGM) system in the United Kingdom. San Diego–based Dexcom designed the Dexcom One system as an easy-to-use, real-time CGM (rt-CGM) that it aims to make more affordable and accessible for people with diabetes in the UK. Get the full story at our […]
Patient Monitoring
BrainCheck appoints new chief financial, revenue officers
BrainCheck announced today that it appointed Trey Swain as its chief financial officer and Matthew Cerullo as chief revenue officer. Houston-based BrainCheck, which develops rapid, mobile cognitive assessment and decision support technology, said in a news release that the personnel announcement follows a $10 million Series B funding round completed in November 2021 as the […]
Analysts say high payor coverage, increased CGM adoption bodes well for Abbott, Dexcom
Analysts have suggested that companies like Abbott (NYSE:ABT) and Dexcom (Nasdaq:DXCM) may benefit from expected reimbursement progress. BTIG hosted a conference call with North Shore Medical Center (Salem, Massachusetts) Medical Director Dr. Gary Cohen and Healthcare Analytics, LLC analyst and consultant Dr. Joshua Cohen. The two experts offered insights into prescriber and patient interest in continuous glucose monitors (CGMs) […]
Terumo, Glooko partner for diabetes data sharing with insulin patch pump
Terumo (TSE:4543) and Glooko today announced a collaboration to integrate their technologies and create new diabetes data sharing solutions. In the new technology integration, users with diabetes will be able to transfer recorded data from the Terumo Medisafe With insulin patch pump into the Glooko management platform, allowing for the visualization of insulin dosage, food and activities in […]
Owens & Minor completes $1.6B acquisition of Apria
Owens & Minor (NYSE:OMI) announced today that it closed its previously announced $1.6 billion acquisition of Apria. The Richmond, Virginia-based company previously announced the planned acquisition of Apria, a developer of home medical equipment for respiratory therapy, sleep apnea treatment, negative pressure wound therapy, and continuous glucose monitoring, in January 2022. According to a news […]
FDA clears Biobeat’s remote vital sign monitoring system
Biobeat announced today that it received FDA 510(k) clearance for its wearable remote patient monitoring device. FDA clearance allows the wearable device to monitor respiratory rate and body temperature in addition to cuffless blood pressure, blood oxygen saturation and pulse rate. Petah Tikva, Israel-based Biobeat’s wireless wrist and chest monitoring devices became the first of […]
Dexcom’s board approves 4-for-1 forward stock split
Dexcom (Nasdaq:DXCM) announced today that its board of directors approved a four-for-one forward split of the company’s common stock. San Diego-based Dexcom’s stock split remains contingent upon stockholder approval of a restated certificate of incorporation. Get the full story at our sister site, Drug Delivery Business News.
Japan approves expanded reimbursement coverage for Abbott’s FreeStyle Libre CGM
Abbott (NYSE:ABT) announced today that it received expanded reimbursement coverage in Japan for the FreeStyle Libre system. Japan’s Ministry of Health, Labour and Welfare approved the expansion for the continuous glucose monitoring (CGM) system to include all people with diabetes who use insulin at least once per day. Get the full story at our sister site, […]
9am.health partners with Ascensia to add blood glucose meter to diabetes toolkit
9am.health announced today that it now offers the Ascensia Diabetes Care Contour Next One and Contour Next products in its diabetes kit. Patients with type 2 diabetes and prediabetes can now add Ascensia’s Contour Next One blood glucose meter and Contour Next glucose test strips to a personalized treatment plan as part of the all-in-one virtual diabetes care […]
Ypsomed partners with CamDiab on smartphone-based automated insulin delivery
Ypsomed (SWX:YPSN) announced today that it partnered with CamDiab to collaborate on managing automated insulin delivery with a mobile app. The partnership aims to launch CamDiab’s CamAPS FX app for managing glucose levels via insulin pumps using an adaptive, hybrid closed-loop approach, for automated insulin delivery (AID) with Ypsomed’s MyLife YpsoPump system during the first half of 2022. […]
BioSig Technologies announces $3M offering
BioSig Technologies (Nasdaq:BSGM) announced today that it entered into a definitive purchase agreement to sell $3 million in common stock. Westport, Connecticut-based BioSig agreed to sell $3 million in common stock and warrants in the agreement led by a family office with expertise in small-cap emerging growth investing. Under the agreement, BioSig will issue 2,611,739 […]